Poolbeg Pharma reveal 'exciting step' with AI data analysis programme with Eurofins Genomics

Poolbeg Pharma PLC (AIM:POLB) chief executive Jeremy Skillington joins Proactive London’s Katie Pilbeam to talk about their deal with testing and support specialist, Eurofins Genomics.

The partnership is to complete the next-generation RNA sequencing of respiratory syncytial virus (RSV) disease progression samples from human viral challenge studies.

The project with Eurofins is expected to be completed by the end of 2021.